Respiratory

Metformin, commonly prescribed for diabetes, may reduce the risks of exacerbation and hospitalization in patients with chronic obstructive pulmonary disease (COPD).

A newly published study recommends annual DXA screenings for patients in the first 2 years after lung transplants to monitor bone mineral density (BMD) changes.

Children with asthma, particularly those with an early onset, may experience slower memory development and face challenges in cognitive functions.

Researchers have developed a precision phenotyping algorithm that significantly advances the identification of long COVID, or post-acute sequelae of COVID-19 (PASC), in patient records.

The FDA has announced it is proposing removing oral phenylephrine from the list of over-the-counter (OTC) nasal decongestant ingredients due to extensive evidence questioning its effectiveness.

New research highlights the significant impact of Respiratory Syncytial Virus (RSV) vaccines in reducing severe respiratory illness among older adults, a group disproportionately affected by RSV.

Ensifentrine, an innovative dual bronchodilator and anti-inflammatory medication, has shown promising results in reducing healthcare usage among patients with moderate to severe chronic obstructive pulmonary disease (COPD).

Critical insights into outpatient antibiotic use and treatment failure rates among U.S. children diagnosed with pneumonia, underscoring significant gaps in care, have been revealed in a new study.